Link to this page
Biological and Environmental Research Ontology
Last uploaded:
December 23, 2022
| Id | http://purl.obolibrary.org/obo/NCIT_C173552
http://purl.obolibrary.org/obo/NCIT_C173552
|
|---|---|
| Preferred Name | MVA-BN Smallpox Vaccine |
| Definitions |
A vaccine consisting of modified vaccinia Ankara-Bavarian Nordic (MVA-BN), a live, attenuated, non-replicating, proprietary version of the MVA virus, used for the prevention of smallpox and monkeypox, with potential antineoplastic activity. Upon intratumoral administration, MVA-BN smallpox vaccine may induce both cellular and humoral immune responses, which may lead to tumor cell lysis.
|
| Type | http://www.w3.org/2002/07/owl#Class |
All Properties
| definition | A vaccine consisting of modified vaccinia Ankara-Bavarian Nordic (MVA-BN), a live, attenuated, non-replicating, proprietary version of the MVA virus, used for the prevention of smallpox and monkeypox, with potential antineoplastic activity. Upon intratumoral administration, MVA-BN smallpox vaccine may induce both cellular and humoral immune responses, which may lead to tumor cell lysis. |
|---|---|
| prefLabel | MVA-BN Smallpox Vaccine
|
| label | MVA-BN Smallpox Vaccine
|
| NCI_META_CUI | CL1407321
|
| PDQ_Closed_Trial_Search_ID | 801908
|
| code | C173552
|
| prefixIRI | NCIT:C173552
|
| in_subset | |
| Preferred_Name | MVA-BN Smallpox Vaccine
|
| FDA_UNII_Code | TU8J357395
|
| Contributing_Source | FDA
|
| Maps_To | MVA-BN Smallpox Vaccine
|
| CAS_Registry | 1026718-04-6
|
| NCI_Drug_Dictionary_ID | 801908
|
| type | |
| Is_Value_For_GDC_Property | |
| subClassOf | |
| PDQ_Open_Trial_Search_ID | 801908
|
| Semantic_Type | Pharmacologic Substance
|
| Delete | Subject | Author | Type | Created |
|---|---|---|---|---|
| No notes to display |